REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
6.76
-0.39 (-5.45%)
Apr 1, 2025, 4:00 PM EDT - Market closed
REGENXBIO Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 57.53 | 34.52 | 96.95 | 345.21 | 338.43 | Upgrade
|
| Short-Term Investments | 177.16 | 240.74 | 267.69 | 112.23 | 137.31 | Upgrade
|
| Cash & Short-Term Investments | 234.69 | 275.26 | 364.64 | 457.44 | 475.74 | Upgrade
|
| Cash Growth | -14.74% | -24.51% | -20.29% | -3.85% | 60.61% | Upgrade
|
| Accounts Receivable | 20.47 | 24.79 | 28.08 | 28.51 | 43.35 | Upgrade
|
| Other Receivables | 12.4 | 19.3 | 8.5 | - | - | Upgrade
|
| Receivables | 32.87 | 44.09 | 36.59 | 28.51 | 43.35 | Upgrade
|
| Prepaid Expenses | 9.07 | 14.52 | 13.9 | 18.75 | 10.51 | Upgrade
|
| Other Current Assets | 1.38 | 1.11 | 0.85 | 14.12 | 1.6 | Upgrade
|
| Total Current Assets | 278 | 334.97 | 415.98 | 518.83 | 531.2 | Upgrade
|
| Property, Plant & Equipment | 171.31 | 192.59 | 206.8 | 192.45 | 120.28 | Upgrade
|
| Long-Term Investments | 10.18 | 38.87 | 200.56 | 391.91 | 47.91 | Upgrade
|
| Long-Term Accounts Receivable | 0.47 | 0.7 | 1.5 | 2.26 | 3.27 | Upgrade
|
| Other Long-Term Assets | 6.03 | 6.84 | 8.43 | 8.46 | 5.51 | Upgrade
|
| Total Assets | 465.99 | 573.97 | 833.27 | 1,114 | 708.16 | Upgrade
|
| Accounts Payable | 22.8 | 22.79 | 27.21 | 11.39 | 10.62 | Upgrade
|
| Accrued Expenses | 37.91 | 49.32 | 45.99 | 59.5 | 38.09 | Upgrade
|
| Current Portion of Long-Term Debt | 34.31 | 50.57 | 48.6 | 37.89 | 18.79 | Upgrade
|
| Current Portion of Leases | 7.9 | 7.07 | 6 | 1.75 | 2.5 | Upgrade
|
| Current Income Taxes Payable | - | - | - | 11.33 | 3.14 | Upgrade
|
| Current Unearned Revenue | 0.12 | 0.15 | 1.83 | 3.33 | 0.45 | Upgrade
|
| Other Current Liabilities | 0.16 | 0.39 | 0.81 | 5.29 | 7.85 | Upgrade
|
| Total Current Liabilities | 103.19 | 130.27 | 130.43 | 130.47 | 81.45 | Upgrade
|
| Long-Term Debt | 25.38 | 43.49 | 89.01 | 133.46 | 174.5 | Upgrade
|
| Long-Term Leases | 74.13 | 82.22 | 88.8 | 84.93 | 70.15 | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | - | 3.78 | Upgrade
|
| Other Long-Term Liabilities | 3.64 | 6.25 | 8.83 | 0.75 | 0.52 | Upgrade
|
| Total Liabilities | 206.34 | 262.23 | 317.07 | 349.61 | 330.41 | Upgrade
|
| Common Stock | 0.01 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 1,193 | 1,021 | 973.15 | 928.1 | 667.18 | Upgrade
|
| Retained Earnings | -932.15 | -705.05 | -441.55 | -161.23 | -289.07 | Upgrade
|
| Comprehensive Income & Other | -0.74 | -4.43 | -15.4 | -2.57 | -0.36 | Upgrade
|
| Total Common Equity | 259.65 | 311.74 | 516.2 | 764.3 | 377.75 | Upgrade
|
| Shareholders' Equity | 259.65 | 311.74 | 516.2 | 764.3 | 377.75 | Upgrade
|
| Total Liabilities & Equity | 465.99 | 573.97 | 833.27 | 1,114 | 708.16 | Upgrade
|
| Total Debt | 141.72 | 183.34 | 232.41 | 258.03 | 265.95 | Upgrade
|
| Net Cash (Debt) | 103.15 | 130.79 | 332.8 | 591.32 | 256.6 | Upgrade
|
| Net Cash Growth | -21.13% | -60.70% | -43.72% | 130.45% | -33.99% | Upgrade
|
| Net Cash Per Share | 2.08 | 2.99 | 7.71 | 13.47 | 6.88 | Upgrade
|
| Filing Date Shares Outstanding | 50.09 | 44.43 | 43.46 | 42.95 | 42.5 | Upgrade
|
| Total Common Shares Outstanding | 49.55 | 44.05 | 43.3 | 42.83 | 37.48 | Upgrade
|
| Working Capital | 174.81 | 204.7 | 285.54 | 388.35 | 449.75 | Upgrade
|
| Book Value Per Share | 5.24 | 7.08 | 11.92 | 17.84 | 10.08 | Upgrade
|
| Tangible Book Value | 259.65 | 311.74 | 516.2 | 764.3 | 377.75 | Upgrade
|
| Tangible Book Value Per Share | 5.24 | 7.08 | 11.92 | 17.84 | 10.08 | Upgrade
|
| Machinery | 88.42 | 87.38 | 83.68 | 68.05 | 34.18 | Upgrade
|
| Leasehold Improvements | 101.47 | 101.93 | 99.4 | 92.54 | 44.96 | Upgrade
|
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.